Compositions and methods for vaccinating against HSV-2
US8840904B2 · kind B2 · utility
0Cited by
20References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 15, 2013 |
| Grant date | Sep 23, 2014 |
| Priority date | — |
| Expiry date | Mar 15, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16634
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV VP11/12 polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.